What if the key to fixing pharma’s toughest challenges wasn’t more complexity—but more clarity? In this episode of Med Tech Gurus, Shetal Vyas, SVP of Commercial Strategy & Development at Ardelyx, joins us to explore how digital-first strategies are reshaping how we bring therapies to patients. Shetal unpacks how to overcome the $200 billion patent cliff, reframe customer engagement, and build scalable, data-driven commercial models that don’t just add tech—but center patients. With practical insights into digital ecosystems, commercialization frameworks, and change management, this episode is packed with takeaways for MedTech innovators navigating the intersection of healthcare, pharma, and digital transformation.
What if we could detect Alzheimer’s disease before the first memory fades? In this powerful episode of Med Tech Gurus, Dr. Maria-Magdalena Patru, MD, PhD—who leads the neurology medical team at Roche Diagnostics US—explains how early diagnosis is being radically transformed through CSF and blood-based biomarker innovations. With Alzheimer’s affecting over 7 million Americans, Dr. Patru outlines how new guidelines, improved reimbursement, and diagnostic advances are helping clinicians identify the disease earlier—when treatments can still preserve cognition. She also shares how her personal connection to Alzheimer’s drives her mission and offers advice to innovators navigating regulatory and clinical pathways. If you're building diagnostics or working on access-to-care challenges, this is a must-listen. https://www.medtechgurus.com https://diagnostics.roche.com/us/en/products/product-category/neurology/alzheimers-disease.html
What if the future of clinical trials wasn’t just faster—but dramatically more human-centered, efficient, and aligned with real-world outcomes? In this episode of Med Tech Gurus, Meri Beckwith, co-founder of Lindus Health, shares how a broken experience during a COVID trial sparked a revolution in trial design. Lindus is reimagining the traditional CRO with fixed-cost models, milestone-based payments, and tech-driven platforms that cut enrollment timelines by 74%. Meri reveals how their innovative culture, AI-enhanced monitoring, and focus on patient experience is building a new infrastructure for smarter trials. If you're a medtech founder tired of bloated protocols, poor enrollment, and outdated systems, this episode will help you rethink what’s possible in clinical research.
What if you could cut your product development time in half—and avoid the regulatory landmines that derail most startups? In this episode of Med Tech Gurus, Marcel Botha, CEO and Founder of 10XBeta, reveals how his Brooklyn-based venture studio helps innovators turn bold ideas into compliant, fundable, and scalable medical technologies. With deep expertise in design, engineering, and regulatory strategy, Marcel shares how 10XBeta supports founders in navigating the critical—and capital-intensive—first mile of MedTech development. From pandemic-driven ventilator designs to launching 50+ products, Marcel delivers powerful lessons on speed, structure, and investor alignment. Gurus, if you’re building in the deep end of innovation, this episode is your blueprint.
What happens when clinical strategy, bioinformatics, and market access all live under one roof? Meet Tyler O’Malley, VP at Exagen, who shares how this rare triad is driving innovation in autoimmune diagnostics. In this episode, Tyler reveals how real-world data fuels product strategy, why storytelling is key to market access, and how diagnostic innovators can scale in a payer-driven world. We explore the evolution of evidence, the importance of physician advocacy, and how to align science with unmet clinical need—without chasing shiny objects. Gurus, if you're launching diagnostics or navigating commercialization in today’s complex environment, this episode is full of insight you can’t afford to miss.
Behavioral health is in crisis—not just from rising demand, but from the chaos of inconsistent care models, fragmented data, and outdated systems. In this episode of Med Tech Gurus, Jim Szyperski, CEO of Acuity Behavioral Health, shares how his team is bringing much-needed structure and accountability to inpatient psychiatric care. Backed by a $1.5 million seed round and in collaboration with health systems, Acuity is creating data-driven standards that empower nurses, improve patient outcomes, and deliver operational clarity. Jim brings lessons from decades of entrepreneurship and dives into the real-world challenges of scaling innovation in healthcare’s slowest-moving sector. Gurus, if you care about solving systemic gaps in mental health care, this conversation is a must.
What if we could finally put real answers behind the brain fog, fatigue, and lingering symptoms so many patients still face post-COVID? In this episode, Dr. Nigel McCracken, Chief Operating Officer at Virax Biolabs, returns to Med Tech Gurus to reveal how their groundbreaking ViraxImmune platform is decoding the hidden dysfunctions of the immune system. With major NHS-led trials underway and U.S. clinical sites ramping up, Nigel shares how their proprietary FluoroSpot T-cell assay brings unprecedented accuracy to diagnosing long COVID, chronic fatigue, and post-viral syndromes. We also dive into the operational challenges of global trials, lessons from diagnostics commercialization, and how to build innovation-ready teams that scale. Gurus, this is diagnostic disruption at its best.
Billions are being poured into healthcare AI, yet most innovations never make it past pilot projects. Why? And more importantly—how do we fix it? In this episode of Med Tech Gurus, we sit down with Marco Smit, serial entrepreneur, life sciences executive, and AI commercialization expert. With leadership experience at Roche, Genentech, Gesund.ai, CareSyntax, and now Domelabs.ai, Marco has seen the full spectrum of healthcare AI—from hype to hard-earned success. He shares why so many organizations fall victim to “pilotitis”, the critical role of AI governance, and how startups and health systems can build scalable, evidence-driven solutions that actually deliver ROI. From navigating the complex regulatory landscape to choosing the right investors and partners, Marco offers a pragmatic playbook for moving AI from the lab to real clinical impact. Whether you’re a startup founder, health system innovator, or medtech investor, this episode is packed with actionable insights on avoiding hype, accelerating adoption, and building AI solutions that last.
What if we could finally crack the code on treating brain cancer by opening the door that’s blocked 98% of therapies? In this episode, Dr. Michael Canney, Chief Scientific Officer of Carthera, reveals how SonoCloud—a revolutionary ultrasound implant—temporarily opens the blood-brain barrier to deliver chemotherapy directly to tumors like glioblastoma. With over 100 patients enrolled in a Phase III trial across 40 global sites, this isn’t just a bold idea—it’s happening now. Michael also shares real-world lessons in scaling trials, FDA navigation, and aligning science with commercial success. If you’re passionate about disruptive innovation in neuro-oncology, you’ll want to hear how Carthera is changing the game.
What if the key to solving the provider burnout crisis wasn’t adding more hours in the day—but using technology to give them back? In this episode of Med Tech Gurus, we meet David Norris, Co-Founder and CEO of Affinion Health. David shares how his company is building an AI-powered clinical inbox that helps clinicians manage the overwhelming flood of lab results, patient messages, and admin tasks. With measurable results like five hours of reclaimed time per week per provider, David explains how Affinion’s solution is not just about efficiency—it’s about restoring balance, improving care, and preventing burnout. From his work with the Coalition for Health AI to his lessons in entrepreneurship and team-building, David offers practical wisdom for every MedTech innovator in this episode.
What if surgeons could eliminate the guesswork from complex procedures and walk into the OR with a personalized, pre-fitted solution ready to go? In this episode, we meet Vikram Ahuja, Co-Founder and CEO of OsseoLabs, who is transforming orthopedic and maxillofacial surgery using AI and 3D printing. Vikram reveals how his platform builds patient-specific implants using biomechanical data—dramatically reducing OR time, complications, and the need for revision surgeries. With over 170 successful cases and 40 hospital partners across Southeast Asia, Vikram shares what’s next, what’s needed for U.S. expansion, and how OsseoLabs is pushing the boundaries of surgical precision. If you're serious about MedTech innovation, this one’s essential listening.
What turns a brilliant idea into a market-ready medical device? Jennifer Palinchik, CEO of SageMar Medical, has spent over two decades guiding innovators through that exact journey. In this episode, Jennifer shares the critical factors that determine whether your device gets adopted—or ends up on the shelf. From navigating regulatory hurdles and defining market value to aligning R&D with commercialization from day one, Jennifer reveals the strategic playbook that every MedTech founder should know. We also explore trends like AI, mixed reality, and the growing role of M&A in accelerating innovation. If you're building in healthtech, Jennifer’s insights will help you avoid costly missteps and build a business that truly scales.
Gurus, what if treating prostate cancer no longer required surgery, blood loss, or hospital stays? In this episode, we sit down with Dr. Arun Menawat, CEO of Profound Medical, who is leading a bold transformation in prostate cancer care. With Tulsa Pro—an AI-powered, MRI-guided, incision-free therapy—his team is challenging the surgical status quo head-on. Arun shares how his journey through imaging innovation shaped this breakthrough, and why he believes the future of interventional medicine will be bloodless, precise, and radically patient-centric. This one’s not just disruptive—it’s redefining what cancer treatment can be.
What if your hospital could see, hear, and understand everything happening in the OR—and actually use that data to drive real-time improvements? Dr. Andrew Gostine, CEO and co-founder of Artisight, is making that vision a reality. With AI-powered computer vision and ambient listening, Artisight enables hospitals to automate documentation, reduce delays, and even prevent wrong-site surgeries. Now partnered with industry giants like NVIDIA and Karl Storz, Artisight is helping over 400 hospitals transform their perioperative workflows—enhancing safety, equity, and efficiency at scale. In this episode, we explore how intelligent automation is reshaping surgical care, how Artisight ensures HIPAA compliance, and why clinician-centered innovation is the key to solving healthcare’s most urgent operational challenges.
In a world where healthcare demands more from fewer resources, standing still isn’t an option. Tim Tinnel, EVP and COO of IntelliGuard, reveals how automation, AI, and intelligent ecosystems are redefining medication management, boosting patient safety, and cutting through operational chaos. We dig into why innovation must be continuous, how true partnerships drive breakthrough solutions, and what it really takes to future-proof hospitals. If you're ready to learn how today’s smartest leaders are reshaping healthcare from the inside out, this episode will change how you think about the future.
What if one small valve could change the lives of millions suffering from chronic venous insufficiency? In this episode, we sit down with Rob Berman, CEO of EnVVeno Medical, to explore how his team is disrupting vascular care with the groundbreaking VenoValve—the first surgical solution for deep vein reflux. Rob shares how this innovation is restoring quality of life, slashing wound care costs, and opening doors for future transcatheter therapies like ENVE. You'll hear hard-earned lessons on leadership, FDA navigation, and raising $135 million to bring first-in-class technology to market. From the OR to investor boardrooms, Rob’s journey is packed with grit, insight, and purpose. If you’re innovating in medtech, this one’s a masterclass.
Gurus, what if the way we transport life-saving medications like insulin or biologics didn’t depend on ice packs, bulky compressors, or outdated infrastructure? What if you could carry a high-performance cold chain system in your backpack—and it held temperature for over 100 hours on a single charge? Meet Faizan Ahmed, CEO of Invensify, the visionary behind Insurg, a solid-state refrigeration technology set to transform not only pharmaceutical logistics—but potentially electric vehicles, outdoor gear, and even chip cooling systems. Inspired by a personal mission to help his father safely travel with insulin, Faizan has gone deep into the science of thermoelectric cooling, building a lightweight, battery-efficient system from the ground up—earning over 50 patents in the process. In this episode, we explore: Why solid-state cooling is the future of cold chain logistics How deep tech meets real-world usability The balance between innovation and commercialization And why IP protection is crucial in a globalized, AI-powered world If you’re curious about how startups can disrupt entrenched industries—and do it with purpose—you won’t want to miss this episode.
Gurus, what if one of the most overlooked causes of hospital harm—and cost—was also one of the most preventable? Meet Martin Burns, CEO of Bruin Biometrics, a leader in predictive diagnostics aiming to retire outdated wound care models. From the battlefields of hospital-acquired conditions to the boardrooms of investors, Martin is on a mission to reimagine pressure injury prevention through biology-based strategies, AI-driven insights, and a handheld device that can detect damage before it breaks the skin. In this episode, we dive into: How Martin transitioned from Deloitte consultant to startup CEO Why prevention still struggles to gain traction in a treatment-focused system The five-step “Formulas” strategy that propelled BBI toward becoming the new standard of care And why real innovation starts with listening—not just to data, but to patients and providers This isn’t just about better tech—it’s about creating healthcare systems that don’t wait for harm to act. You will love the insights that Martin brings in this episode.
Gurus, imagine a future where your voice can flag early signs of Parkinson’s or PTSD—where your smartwatch data helps build global research—and where you, not the system, own your health data. That future is already unfolding, and today’s guest is helping to build it. Meet Mack Stachowiak, CTO of AxonDAO, a pioneer in blending AI, wearable technology, and decentralized science to revolutionize healthcare. From launching telemedicine platforms in the pre-smartphone era to building the Q-Ring wearable that seamlessly tracks thousands of biometrics, Mack is rethinking how data, diagnostics, and access intersect. In this episode, we explore how AI can speed diagnostics, how blockchain empowers patients, and why voice biomarkers might be the most non-invasive—and powerful—tool in early disease detection. If you're curious about the future of patient-owned data, smart algorithms, and tech that listens—literally—you won’t want to miss this conversation. Let’s dive in!
Gurus, what happens when a med student asks for a 3D printer for their birthday? For Dhruv Agrawal, Co-Founder and CEO of Aether Biomedical, that gift became the launchpad for a global MedTech breakthrough. In this episode, Dhruv shares how he went from medical school to creating the Zeus Hand—the world’s first fully remote-adjustable, repairable, and Medicare-reimbursable bionic hand. With over 800 devices in use across 15 countries, Dhruv didn’t just build better hardware—he built an ecosystem that empowers clinicians and patients alike. We dive into how real-world feedback fueled innovation, why cloud-based platforms are changing prosthetic care, and how clear product-market fit starts when clinicians become your best salespeople. It’s a story of grit, learning, and the power of solving the right problem.